Acute exacerbation of interstitial lung disease after procedures

William H. Amundson; Emilian Racila; Tadashi Allen; H. Erhan Dincer; Rade Tomic; Maneesh Bhargava; David M. Perlman; Hyun Joo Kim

doi:10.1016/j.rmed.2019.02.012

Acute exacerbation of interstitial lung disease after procedures

William H. Amundson, Emilian Racila, Tadashi Allen, H. Erhan Dincer, Rade Tomic, Maneesh Bhargava, David M. Perlman, Hyun Joo Kim^*

^*Corresponding author for this work

Medicine, Pulmonary Division

Research output: Contribution to journal › Review article › peer-review

43 Scopus citations

Abstract

Interstitial lung disease (ILD) is a category of diffuse parenchymal lung diseases characterized by inflammation and/or fibrosis. The best characterized ILD is idiopathic pulmonary fibrosis (IPF). Acute exacerbation of IPF is a dreaded occurrence with grim prognosis and suboptimal treatment options. There have been recent reports that acute exacerbation can occur in other ILDs (AE-ILD). Of note, some of these acute exacerbations follow lung procedures. This review summarizes the available information on AE-ILD and discusses the procedures reported to cause AE-ILD. We also discuss proposed mechanisms, risk factors, treatment and prognosis. This review should help to inform decision-making about risks versus benefits of procedures that are commonly recommended to diagnose ILD.

Original language	English (US)
Pages (from-to)	30-37
Number of pages	8
Journal	Respiratory Medicine
Volume	150
DOIs	https://doi.org/10.1016/j.rmed.2019.02.012
State	Published - Apr 2019

Keywords

AE-ILD
Acute exacerbation
Acute exacerbation of interstitial lung disease
Interstitial lung disease
Lung biopsy

ASJC Scopus subject areas

Pulmonary and Respiratory Medicine

Access to Document

10.1016/j.rmed.2019.02.012

Cite this

@article{877c71cfe6804e2cae2731cdd3342c14,

title = "Acute exacerbation of interstitial lung disease after procedures",

abstract = "Interstitial lung disease (ILD) is a category of diffuse parenchymal lung diseases characterized by inflammation and/or fibrosis. The best characterized ILD is idiopathic pulmonary fibrosis (IPF). Acute exacerbation of IPF is a dreaded occurrence with grim prognosis and suboptimal treatment options. There have been recent reports that acute exacerbation can occur in other ILDs (AE-ILD). Of note, some of these acute exacerbations follow lung procedures. This review summarizes the available information on AE-ILD and discusses the procedures reported to cause AE-ILD. We also discuss proposed mechanisms, risk factors, treatment and prognosis. This review should help to inform decision-making about risks versus benefits of procedures that are commonly recommended to diagnose ILD.",

keywords = "AE-ILD, Acute exacerbation, Acute exacerbation of interstitial lung disease, Interstitial lung disease, Lung biopsy",

author = "Amundson, {William H.} and Emilian Racila and Tadashi Allen and Dincer, {H. Erhan} and Rade Tomic and Maneesh Bhargava and Perlman, {David M.} and Kim, {Hyun Joo}",

note = "Publisher Copyright: {\textcopyright} 2019 Elsevier Ltd",

year = "2019",

month = apr,

doi = "10.1016/j.rmed.2019.02.012",

language = "English (US)",

volume = "150",

pages = "30--37",

journal = "Respiratory Medicine",

issn = "0954-6111",

publisher = "W.B. Saunders Ltd",

}

TY - JOUR

T1 - Acute exacerbation of interstitial lung disease after procedures

AU - Amundson, William H.

AU - Racila, Emilian

AU - Allen, Tadashi

AU - Dincer, H. Erhan

AU - Tomic, Rade

AU - Bhargava, Maneesh

AU - Perlman, David M.

AU - Kim, Hyun Joo

PY - 2019/4

Y1 - 2019/4

N2 - Interstitial lung disease (ILD) is a category of diffuse parenchymal lung diseases characterized by inflammation and/or fibrosis. The best characterized ILD is idiopathic pulmonary fibrosis (IPF). Acute exacerbation of IPF is a dreaded occurrence with grim prognosis and suboptimal treatment options. There have been recent reports that acute exacerbation can occur in other ILDs (AE-ILD). Of note, some of these acute exacerbations follow lung procedures. This review summarizes the available information on AE-ILD and discusses the procedures reported to cause AE-ILD. We also discuss proposed mechanisms, risk factors, treatment and prognosis. This review should help to inform decision-making about risks versus benefits of procedures that are commonly recommended to diagnose ILD.

AB - Interstitial lung disease (ILD) is a category of diffuse parenchymal lung diseases characterized by inflammation and/or fibrosis. The best characterized ILD is idiopathic pulmonary fibrosis (IPF). Acute exacerbation of IPF is a dreaded occurrence with grim prognosis and suboptimal treatment options. There have been recent reports that acute exacerbation can occur in other ILDs (AE-ILD). Of note, some of these acute exacerbations follow lung procedures. This review summarizes the available information on AE-ILD and discusses the procedures reported to cause AE-ILD. We also discuss proposed mechanisms, risk factors, treatment and prognosis. This review should help to inform decision-making about risks versus benefits of procedures that are commonly recommended to diagnose ILD.

KW - AE-ILD

KW - Acute exacerbation

KW - Acute exacerbation of interstitial lung disease

KW - Interstitial lung disease

KW - Lung biopsy

UR - http://www.scopus.com/inward/record.url?scp=85061673819&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85061673819&partnerID=8YFLogxK

U2 - 10.1016/j.rmed.2019.02.012

DO - 10.1016/j.rmed.2019.02.012

M3 - Review article

C2 - 30961948

AN - SCOPUS:85061673819

SN - 0954-6111

VL - 150

SP - 30

EP - 37

JO - Respiratory Medicine

JF - Respiratory Medicine

ER -

Acute exacerbation of interstitial lung disease after procedures

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this